Eric Aragón
Impact in
-
- TGF-β signaling in diseases
- Ubiquitin and proteasome pathways
- Cancer-related gene regulation
- Wnt/β-catenin signaling in development and cancer
- RNA Research and Splicing
- Chemical Synthesis and Analysis
- Cell Biology top 10%
- Hippo pathway signaling and YAP/TAZ
Papers in
-
- TGF-β signaling in diseases 6
- Cancer-related gene regulation 5
- Glycosylation and Glycoproteins Research 3
- Chemical Synthesis and Analysis 3
- Ubiquitin and proteasome pathways 3
-
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- María J. Macias (19 shared papers)Joan Massagué (5 shared papers)Qiaoran Xi (3 shared papers)Nina Goerner (2 shared papers)Albert Escobedo (2 shared papers)Tiago Gomes (6 shared papers)Pau Martín-Malpartida (15 shared papers)Lidia Ruíz (10 shared papers)
- Journals
- Nature Communications (4 papers)The Journal of Clinical Pharmacology (3 papers)Structure (2 papers)Genes & Development (2 papers)Computational and Structural Biotechnology Journal (2 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Eric Aragón
28 papers receiving 802 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 566
- Cell Biology 118
- Structural Biology 9
- Oncology 111
- Cancer Research 57
Countries citing papers authored by Eric Aragón
This map shows the geographic impact of Eric Aragón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Aragón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Aragón more than expected).
Fields of papers citing papers by Eric Aragón
This network shows the impact of papers produced by Eric Aragón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Aragón. The network helps show where Eric Aragón may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Aragón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 206 | |
| 2 | 2017 | 90 | |
| 3 | 2012 | 83 | |
| 4 | 2019 | 72 | |
| 5 | 2014 | 51 | |
| 6 | 2008 | 46 | |
| 7 | 2018 | 36 | |
| 8 | 1989 | 30 | |
| 9 | 2021 | 23 | |
| 10 | 2013 | 20 | |
| 11 | 2011 | 19 | |
| 12 | 2006 | 19 | |
| 13 | 2021 | 16 | |
| 14 | Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone. | 1988 | 13 |
| 15 | 2013 | 12 | |
| 16 | 2022 | 11 | |
| 17 | 2001 | 11 | |
| 18 | 2016 | 9 | |
| 19 | 2021 | 8 | |
| 20 | 2009 | 8 |
About Eric Aragón
Eric Aragón is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Cardiology and Cardiovascular Medicine, Cell Biology and Pathology and Forensic Medicine, having authored 28 papers that have together received 812 indexed citations. Recurring topics across this work include TGF-β signaling in diseases (6 papers), Cancer-related gene regulation (5 papers), Cardiac Arrhythmias and Treatments (4 papers), Cardiac electrophysiology and arrhythmias (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Chemical Synthesis and Analysis (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Molecular Biology (566 citations), Cell Biology (118 citations), Structural Biology (9 citations), Oncology (111 citations) and Cancer Research (57 citations). Eric Aragón has collaborated with scholars based in Spain, United States and France. Frequent co-authors include María J. Macias, Joan Massagué, Qiaoran Xi, Nina Goerner, Albert Escobedo, Tiago Gomes, Pau Martín-Malpartida, Lidia Ruíz, Alexia-Ileana Zaromytidou and Sheng Gao. Their work appears in journals such as Nature Communications, The Journal of Clinical Pharmacology, Structure, Genes & Development and Computational and Structural Biotechnology Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.